United States · Platforms & data · MarketBeat

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

Published by MarketBeat · United States 1 h ago

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) have received an average rating of "Moderate Buy" from the eighteen ratings firms that are currently…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

Share

Also worth reading

Prediction: These 3 Stocks Will 10X in the Next 20 Years

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand

AI applications expand, fueling China's economic growth